Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.40 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | CSF3R | Q99062 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 4/20 | 0.32 |
| ▸ | HTR1D | P28221 | 4/20 | 0.32 |
| ▸ | HTR1B | P28222 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16169700 | 0.94 | PIM1 (0.39) | PIM1PIM2RAB9AMAPTLMNA | |
| SCHEMBL15805960 | 0.94 | PIM1 (0.39) | PIM1PIM2CSF3RHCRTR1HTR1B | |
| SCHEMBL16169704 | 0.92 | PIM1 (0.44) | PIM1PIM2RAB9AMAPTLMNA | |
| SCHEMBL15805864 | 0.85 | PIM1 (0.43) | PIM1PIM2CSF3RHCRTR1HTR1B | |
| SCHEMBL16169703 | 0.81 | PIM1 (0.33) | PIM1PIM2CSF3R | |
| SCHEMBL16419754 | 0.76 | BCHE (0.40) | PIM1RAB9AMAPTSMN1; SMN2CYP1A2 | |
| SCHEMBL16169683 | 0.75 | PLA2G2A (0.43) | RAB9ASMN1; SMN2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL16419743 | 0.73 | CHRNB2 (0.43) | RAB9AMAPTLMNASMN1; SMN2CSF3R | |
| SCHEMBL16419737 | 0.73 | SMN1; SMN2 (0.48) | SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP19A1 | |
| SCHEMBL16169687 | 0.73 | SMN1; SMN2 (0.48) | SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | CELLCEUTIX CORPORATION (US) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | ALG1, CD44, MUC1 | PIM1 1725/4885PIM2 2729/4885RAB9A 3646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.